Who owns KARYOPHARM THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Karyopharm Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Karyopharm Therapeutics stock

Who bought or sold KARYOPHARM THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Jpmorgan Chase & Co 765k $5.0M 7948% Sep 2025
 View chart
Simplex Trading 48k $315k 100% Sep 2025
 View chart
Exome Asset Management 48k $315k 100% Sep 2025
 View chart
Group One Trading 34k $221k 814% Sep 2025
 View chart
National Bank Of Canada /fi/ 1.2k $754k 100% Sep 2025
 View chart